You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
藥明康德(02359.HK)擬參與設立合資公司及成立合夥企業
格隆匯 03-08 22:51

格隆匯 3 月 8日丨藥明康德(02359.HK)宣佈,於2021年3月8日,公司全資子公司藥明投資、MeadowSpring、晨壹及蘇州民營資本訂立組織章程細則,設立合資公司。根據組織章程細則,藥明投資同意出資人民幣4500萬元,佔合資公司註冊資本的45%。

合資公司設立後,藥明投資、MeadowSpring、嘉興晨壹(晨壹的全資子公司)、蘇州翼蘇(蘇州民營資本的全資子公司)及合資公司將訂立合夥協議,成立合企業。根據合協議,藥明投資(作為有限合人)將向合企業出資人民幣4500萬元,佔合企業權益的44.55%。 

合資公司計劃在向中國證券投資基金業協會註冊為私募基金管理人後,與合夥企業(作為基金普通合夥人)設立基金。基金為私募基金,專注於健康行業併購。基金將密切觀察健康行業的發展趨勢,把握大中華地區相關結構性成長機遇,重點投資健康行業的中後期標的。基金將進行的有關投資有助公司(其中包括)(i)拓寬生態圈、價值鏈及發展計劃;及(ii)提升和加強於健康行業的地位。日後,倘未來投資計劃可取且符合發展計劃及主要業務,公司或會進一步對基金進行投資。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account